Problem statement: Answer the multiple-choice question.
Query: Which compound exhibits a -33.716% human ether-à-go-go related gene (hERG) inhibition at a concentration of 10uM?
Constraint: You must select none, one or more options from a or b without using any additional words.
Options:
a) CCCCn1c(O)c(/C=N/N2CCCCC2c2cccnc2)c(=O)[nH]c1=S
b) Cc1c(/C=N/NC(=O)c2cccnc2)c2ccccn2c1C(=O)c1ccc(F)cc1
Answer: a. CCCCn1c(O)c(/C=N/N2CCCCC2c2cccnc2)c(=O)[nH]c1=S
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCCCn1c(O)c(/C=N/N2CCCCC2c2cccnc2)c(=O)[nH]c1=S
CCCCn1c(O)c(/C=N/N2CCCCC2c2cccnc2)c(=O)[nH]c1=S
1-butyl-6-hydroxy-5-[(E)-(2-pyridin-3-ylpiperidin-1-yl)iminomethyl]-2-sulfanylidenepyrimidin-4-one